Inventor · disambiguated record
Marius Hoener
Also filed as: HOENER MARIUS
23 granted patents·10 pending applications·46 citations·filing 2000–2023
93Inventor score
Files withHOFFMANN LA ROCHE19HOENER MARIUS5EBELING MARTIN3ROCHE INNOVATION CT COPENHAGEN AS3GALLEY GUIDO1
Top patents by PatentIndex Score
33 records- 0195US12259380B2Oligonucleotides for inducing paternal UBE3A expressionHOFFMANN LA ROCHE·Filed 2023·Granted Mar 25, 2025·2 cites·26 claims
- 0295US11852627B2Oligonucleotides for inducing paternal UBE3A expressionHOFFMANN LA ROCHE·Filed 2022·Granted Dec 26, 2023·3 cites·11 claims
- 0394US11320421B2Oligonucleotides for inducing paternal UBE3A expressionHOFFMANN LA ROCHE·Filed 2020·Granted May 3, 2022·3 cites·16 claims
- 0494US10739332B2Oligonucleotides for inducing paternal UBE3A expressionROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Granted Aug 11, 2020·6 cites·5 claims
- 0593US10718753B2Oligonucleotides for inducing paternal UBE3A expressionROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Granted Jul 21, 2020·5 cites·9 claims
- 0691US10005736B1Pyridine and pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Jun 26, 2018·6 cites·22 claims
- 0790US10494633B2Oligonucleotides for inducing paternal UBE3A expressionROCHE INNOVATION CT COPENHAGEN AS·Filed 2016·Granted Dec 3, 2019·8 cites·24 claims
- 0882US10029989B2Imidazole derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Jul 24, 2018·2 cites·16 claims
- 0981US10092546B2Imidazole derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Oct 9, 2018·3 cites·18 claims
- 1078US10457644B2Pyrazol compounds as EAAT3 inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted Oct 29, 2019·2 cites·13 claims
- 1178US10457663B2Pyrazol-pyridine derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Oct 29, 2019·2 cites·17 claims
- 1278US10273217B2Triazole derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Apr 30, 2019·2 cites·17 claims
- 1375US7875645B2Method for the treatment of CNS disorders with substituted 2-imidazoles or imidazole derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Jan 25, 2011·2 cites·4 claims
- 1472US11312711B2Morpholine derivativeHOFFMANN LA ROCHE·Filed 2020·Granted Apr 26, 2022·0 cites·19 claims
- 1563US2019154664A1Methods for determining the efficacy profile of a drug candidateHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 1663US2019144824A1Standardized neuronal cell assays from primate speciesHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 1759US10508107B2Morpholine derivativeHOFFMANN LA ROCHE·Filed 2018·Granted Dec 17, 2019·0 cites·22 claims
- 1852US10155741B2Pyridine or pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Dec 18, 2018·0 cites·8 claims
- 1948US8193408B2Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can used in the treatment of the above disease states and identification of a nematode geneHOENER MARIUS·Filed 2008·Granted Jun 5, 2012·0 cites·2 claims
- 2047US10556870B2Imidazole compounds as EAAT3 inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Feb 11, 2020·0 cites·10 claims
- 2147US8158668B2Methods for treating CNS disorders with 4-imidazole derivativesGALLEY GUIDO·Filed 2007·Granted Apr 17, 2012·0 cites·3 claims
- 2245US10577332B2Tetrazole derivativesHOFFMANN LA ROCHE·Filed 2016·Granted Mar 3, 2020·0 cites·4 claims
- 2343US7268154B2Substituted triazole compoundsHOFFMANN LA ROCHE·Filed 2006·Granted Sep 11, 2007·0 cites·62 claims
- 2443US2007130631A1TAAR1 transgenic animalHOENER MARIUS·Filed 2006·Application pending·0 cites
- 2543US2013345201A1Pharmaceutical combinationHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2641US2007074297A1TAAR1 knock out animalHOENER MARIUS·Filed 2006·Application pending·0 cites
- 2741US2007197569A1Method for treating central nervous system disorders with substituted 2-imidazoline derivativesHOENER MARIUS·Filed 2007·Application pending·0 cites
- 2840US9132136B2Pharmaceutical combinationHOENER MARIUS·Filed 2011·Granted Sep 15, 2015·0 cites·2 claims
- 2939US7399900B2Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can used in the treatment of the above disease states and identification of anematode geneSANOFI AVENTIS DEUTSCHLAND·Filed 2001·Granted Jul 15, 2008·0 cites·9 claims
- 3039US2006024787A1Chimp trace amine associated receptors and polypeptidesEBELING MARTIN·Filed 2005·Application pending·0 cites
- 3139US2006008880A1Mouse trace amine associated receptors and polypeptidesEBELING MARTIN·Filed 2005·Application pending·0 cites
- 3238US2006009441A1Human trace amine associated receptorsEBELING MARTIN·Filed 2005·Application pending·0 cites
- 3332US2003108893A1Method for establishing neurogically relevant properties of a materialFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marius Hoener files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →